Holen Sie sich die Stockscreener-App
2.12
0.47%
-0.010
Handel nachbörslich:
2.12
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 70.00 | - | - |
Operating Expenses
|
18.20%
10.98
|
13.42 | 15.47 | 18.27 | 18.13 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
18.20%
10.98
|
13.42 | 15.47 | - | - |
| Operating Income/Loss |
18.20%
-10.98
|
-13.42 | 54.53 | -18.27 | -18.13 |
| Nonoperating Income/Loss |
13.26%
2.48
|
2.859 | 2.012 | 2.29 | 2.573 |
| Income/Loss From Continuing Operations Before Tax |
19.53%
-8.498
|
-10.56 | 56.54 | -15.98 | -15.56 |
| Income/Loss From Continuing Operations After Tax |
19.53%
-8.498
|
-10.56 | 56.54 | -15.98 | -15.56 |
|
Net Income/Loss
|
19.53%
-8.498
|
-10.56 | 56.54 | -15.98 | -15.56 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.22%
56.93
|
56.80 | 56.66 | 0.5303 | 56.51 |
| Diluted Average Shares |
0.22%
56.93
|
56.80 | 57.67 | 0.5303 | 56.51 |
| Basic Earnings Per Share |
21.05%
-0.15
|
-0.19 | 1.00 | -0.28 | -0.28 |
| Diluted Earnings Per Share |
21.05%
-0.15
|
-0.19 | 0.98 | -0.28 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):